Skip to content
2000
Volume 19, Issue 26
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

The increase in the therapeutic arsenal in the last 20 years, has given rise to changes in treating colorectal cancer (CRC) with only pyrimidines to combine several cytotoxic drugs. However, the present question is to determine the optimal sequence of this combination. This review presents an update of data on chemical and clinical features of chemotherapy used for colorectal cancer and the mechanisms of cellular resistance and potential predictive and prognostic biomarkers, which may contribute to a better selection of a therapeutic strategy.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986712803251494
2012-09-01
2025-06-24
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986712803251494
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test